Why Scholar Rock Stock Got Socked on Monday
A potential delay in an important submission was the news item driving Scholar Rock's (NASDAQ: SRRK) share price down as the trading week kicked off. On Monday, the biotech's shares fell by more than 13% as a result, contrasting unfavorably with the 1.6% gain of the S 500 (SNPINDEX: ^GSPC).
In a tersely worded post on its website, Scholar Rock divulged that a third-party manufacturing facility it uses, Catalent Indiana, has been tagged by the Food and Drug Administration (FDA) as being Official Action Indicated (OAI).
Image source: Getty Images.
Source Fool.com
